Genistein induces growth inhibition and G2/M arrest in nasopharyngeal carcinoma cells

Nutrition and Cancer

Volumn 62, Issue 5, 2010, Pages 641-647

  Han, Hongyu ^a   Zhong, Caiyun ^b   Zhang, Xuchao ^c   Liu, Ranyi ^a   Pan, Meixia ^c   Tan, Li ^d   Li, Yan ^a   Wu, Jiangxue ^a   Zhu, Yinghui ^a   Huang, Wenlin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA; GENISTEIN; MESSENGER RNA; SELECTIVE ESTROGEN RECEPTOR MODULATOR; ANTINEOPLASTIC AGENT; ATM PROTEIN; ATR PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ESTROGEN RECEPTOR; PROTEIN SERINE THREONINE KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NASOPHARYNX CARCINOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; CELL DIVISION; DIET; DRUG EFFECTS; GENETICS; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PHYSIOLOGY;

ATAXIA TELANGIECTASIA;

ANTICARCINOGENIC AGENTS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL CYCLE PROTEINS; CELL DIVISION; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DIET; G2 PHASE; GENISTEIN; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ESTROGEN;

EID: 77954023779     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003605490     Document Type: Article

References (36)

1. Chang ET and Adami HO: The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15, 1765-1777, 2006.
2. Wiseman M: The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 67, 253-1236, 2008.
3. Steiner C, Arnould S, Scalbert A, and Manach C: Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. Br J Nutr 99(1 Suppl), ES78-E108, 2008.
4. Chang KL, Kung ML, Chow NH, and Su SJ: Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1. Biochem Pharmacol 67, 717-726, 2004.
5. Frey RS, Li J, and Singletary KW: Effects of genistein on cell proliferation and cell cycle arrest in nonneoplastic human mammary epithelial cells: involvement of Cdc2, p21(waf/cip1), p27(kip1), and Cdc25C expression. Biochem Pharmacol 61, 979-989, 2001.
6. Santibanez JF, Navarro A, and Martinez J: Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Res 17, 1199-1204, 1997.
7. Su SJ, Yeh TM, Lei HY, and Chow NH: The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res 6, 230-236, 2000.
8. Yu Z, Li W, and Liu F: Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. Cancer Lett 215, 159-166, 2004.
9. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, and Elgavish A: Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 61, 6777-6782, 2001.
10. PollardMandWolter W: Prevention of spontaneous prostate-related cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet. Prostate 45, 101-105, 2000.
11. Yan CH, Chen XG, Li Y, and Han R: Effects of genistein, a soybeanderived isoflavone, on proliferation and differentiation of B16-BL6 mouse melanoma cells. J Asian Nat Prod Res 1, 285-299, 1999.
12. Akimoto T, Nonaka T, Ishikawa H, Sakurai H, Saitoh JI, et al.: Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways. Int J Radiat Oncol Biol Phys 50, 195-201, 2001.
13. AkiyamaT, Ishida J,Nakagawa S,Ogawara H,Watanabe S, et al.:Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262, 5592-5595, 1987.
14. Alhasan SA, Aranha O, and Sarkar FH: Genistein elicits pleiotropic molecular effects on head and neck cancer cells. Clin Cancer Res 7, 4174-4181, 2001.
15. Lian F, BhuiyanM, Li YW,Wall N, KrautM, et al.: Genistein-induced G2- M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr Cancer 31, 184-191.
16. Myoung H, Hong SP, Yun PY, Lee JH, and Kim MJ: Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion. Cancer Sci 94, 215-220, 2003.
17. Sarkar FH and Li Y: Soy isoflavones and cancer prevention. Cancer Invest 21, 744-757, 2003.
18. Fujimoto N, Sueoka N, Sueoka E, Okabe S, Suganuma M, et al.: Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1. Int J Oncol 20, 1233-1239, 2002.
19. Tatsuta M, Iishi H, Baba M, Yano H, Uehara H, et al.: Attenuation by genistein of sodium-chloride-enhanced gastric carcinogenesis induced by N-methyl-N-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 80, 396-399, 1999. (Pubitemid 29019626)
20. Akiyama T and Ogawara H: Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol 201, 362-370, 1991.
21. Lopez-Lazaro M, Willmore E, and Austin CA: Cells lacking DNA topoisomerase II beta are resistant to genistein. J Nat Prod 70, 763-767, 2007.
22. Markovits J, Junqua S, Goldwasser F, Venuat AM, Luccioni C, et al.: Genistein resistance in human leukaemic CCRF-CEM cells: selection of a diploid cell line with reduced DNA topoisomerase II beta isoform. Biochem Pharmacol 50, 177-186, 1995.
23. Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, et al.: Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49, 5111-5117, 1989.
24. Booher RN, Holman PS, and Fattaey A: Human Myt1 is a cell cycleregulated kinase that inhibits Cdc2 but not Cdk2 activity. J Biol Chem272, 22300-22306, 1997.
25. McGowan CH and Russell P: Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. Embo J 12, 75-85, 1993.
26. Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, et al.: Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 6, 107, 2006.
27. Oki T, Sowa Y, Hirose T, Takagaki N, HorinakaM, et al.: Genistein induces Gadd45 gene and G2/M cell cycle arrest in the DU145 human prostate cancer cell line. FEBS Lett 577, 55-59, 2004.
28. Shao ZM, Alpaugh ML, Fontana JA, and Barsky SH: Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis. J Cell Biochem 69, 44-54, 1998.
29. Choi YH, Zhang L, Lee WH, and Park KY: Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int J Oncol 13, 391-396, 1998.
30. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, et al.: Genistein arrests cell cycle progression at G2-M. Cancer Res 53, 1328-1331, 1993.
31. Medema RH,Klompmaker R, Smits VA, and RijksenG: p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene 16, 431-441, 1998.
32. Tchou WW, Rom WN, and Tchou-Wong KM: Novel form of p21(WAF1/CIP1/SDI1) protein in phorbol ester-induced G2/M arrest. J Biol Chem 271, 29556-29560, 1996.
33. Vauzour D, Vafeiadou K, Rice-Evans C, Cadenas E, and Spencer JP: Inhibition of cellular proliferation by the genistein metabolite 5,7,3',4'- tetrahydroxyisoflavone is mediated by DNA damage and activation of the ATR signalling pathway. Arch Biochem Biophys 468, 159-166, 2007.
34. Canepa ET, Scassa ME,Ceruti JM, Marazita MC,Carcagno AL, et al.: INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 59, 419-426, 2007.
35. Thullberg M, Bartkova J, Khan S, Hansen K, Ronnstrand L, et al. Distinct versus redundant properties among members of the INK4 family of cyclindependent kinase inhibitors. FEBS Lett 470, 161-166, 2000.
36. Ward MH, Pan WH, Cheng YJ, Li FH, Brinton LA, et al.: Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan. Int J Cancer 86, 603-609, 2000.